“49 Table of Content s Interest Expense The following table provides a summary of our Interest expense and average borrowing rate: Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Interest expense (in millions) $ (87) $ (79) $ (259) $ (225) Average borrowing rate 2.9 % 2.8 % 2.9 % 2.8 % Interest expense increased during the third quarter and first nine months of 2025 compared to the prior year period primarily due to a higher average borrowing rate and higher average outstanding debt balances.”
“38 Table of Contents To calculate adjusted net income (loss), adjusted net income (loss) attributable to Boston Scientific common stockholders and adjusted net income (loss) per share, we exclude certain charges (credits) from GAAP net income and GAAP net income attributable to Boston Scientific common stockholders, which include amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), investment portfolio net losses (gains) and impairments, restructuring and restructuring-related net charges (credits), litigation-related net charges (credits), European Union (EU) Medical Device Regulation (MDR) implementation costs, debt extinguishment net charges, deferred tax expenses (benefits) and discrete tax items.”